Savanna Innovation Capital
Savanna Innovation Capital is a Pre-Seed, Seed venture capital firm based in Accra, Ghana investing in Fintech, Other, Real Estate. The firm typically writes $100K–$300K checks and has 27 portfolio companies in our records.
Pre-Seed, Seed
$100K – $300K
27+ companies
1 partner
Investment Thesis
Investing in Ghanaian fintech startups that bring digital transformation to traditional financial services.
How Savanna Innovation Capital invests
Savanna Innovation Capital is a vc firm based in Accra, Ghana. The firm invests at the Pre-Seed, Seed stages, with a focus on Fintech, Other, Real Estate, AI / ML, Consumer. It does not invest in Retail.
Savanna Innovation Capital typically writes checks of $100K–$300K per investment.
Investing since at least 2026, Savanna Innovation Capital has backed 27 companies in our records, including A3 Technologies, Bloodscan Biotech, Camden Space. Its most recent recorded investment was in 2026, with 18 investments logged over the last 12 months.
Meet the Team
Kwame Boateng
General Partner
Industry Focus
Invests In
Does Not Invest In
Portfolio Companies (27)
2026
A3 Technologies
Commercializing the next generation of plasma thrusters for space flight.
Bloodscan Biotech
Commercializing the Labyrinth microfluidic chip, engineered to efficiently isolate and purify circulating tumor cells from peripheral blood for both research and cancer diagnostic purposes.
Camden Space
Commercializing SCD sensors (small enough to fit in the palm of your hand) that provide unparalleled detection of electric charges on spacecraft.
Carbon Scavenger
Helping create the circular carbon economy by capturing CO2 emitted by trains.
Connected Traffic Intelligence
Bringing to market software to allow connected and automated vehicle data to be more readily accessible to traffic engineers.
Corner3d
Commercializing PassFit, a portable 3D anthropometry system measuring standard body dimensions from clothed individuals.
Enexa Bio
Enexa Bio is engineering precision small molecules for autoimmune disease, led by a biomarker-driven lupus nephritis program.
Eradix Therapeutics
Developing Degrader-antibody conjugates for cancer treatment.
General Orbit
Focused on designing and developing applications, simulations, frameworks, for a new hybrid magnetometer and attitude determination and control system (HyMag-ADCS).
HealthyLifetime
Bringing to market a program designed to help older adults maintain their independence as they age.
- •Raising at Pre-Seed, Seed? You're squarely in their sweet spot.
- •Lead with your fit in Fintech, Other, Real Estate — the sectors they actively back.
- •Size your ask to their typical $100K – $300K check.
- •cold outreach ok
- •Address your outreach to a specific partner, such as Kwame Boateng, General Partner.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if Savanna Innovation Capital is a match for your startup
Upload your pitch deck to see how well you match with Savanna Innovation Capital and 10,000+ other investors.
Is this your profile? Request a correction or removal